1. Home
  2. INTS vs ONMD Comparison

INTS vs ONMD Comparison

Compare INTS & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • ONMD
  • Stock Information
  • Founded
  • INTS 2012
  • ONMD 2006
  • Country
  • INTS United States
  • ONMD United States
  • Employees
  • INTS N/A
  • ONMD N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • ONMD
  • Sector
  • INTS Health Care
  • ONMD
  • Exchange
  • INTS Nasdaq
  • ONMD Nasdaq
  • Market Cap
  • INTS 33.4M
  • ONMD 32.5M
  • IPO Year
  • INTS 2023
  • ONMD N/A
  • Fundamental
  • Price
  • INTS $2.13
  • ONMD $0.93
  • Analyst Decision
  • INTS Strong Buy
  • ONMD
  • Analyst Count
  • INTS 3
  • ONMD 0
  • Target Price
  • INTS $8.50
  • ONMD N/A
  • AVG Volume (30 Days)
  • INTS 35.4K
  • ONMD 117.8K
  • Earning Date
  • INTS 03-13-2025
  • ONMD 12-17-2024
  • Dividend Yield
  • INTS N/A
  • ONMD N/A
  • EPS Growth
  • INTS N/A
  • ONMD N/A
  • EPS
  • INTS N/A
  • ONMD 0.01
  • Revenue
  • INTS N/A
  • ONMD $957,651.00
  • Revenue This Year
  • INTS N/A
  • ONMD N/A
  • Revenue Next Year
  • INTS N/A
  • ONMD N/A
  • P/E Ratio
  • INTS N/A
  • ONMD $113.60
  • Revenue Growth
  • INTS N/A
  • ONMD 1.36
  • 52 Week Low
  • INTS $1.50
  • ONMD $0.46
  • 52 Week High
  • INTS $5.94
  • ONMD $3.37
  • Technical
  • Relative Strength Index (RSI)
  • INTS 42.33
  • ONMD 37.79
  • Support Level
  • INTS $2.20
  • ONMD $0.92
  • Resistance Level
  • INTS $2.53
  • ONMD $1.06
  • Average True Range (ATR)
  • INTS 0.33
  • ONMD 0.09
  • MACD
  • INTS -0.01
  • ONMD -0.02
  • Stochastic Oscillator
  • INTS 36.76
  • ONMD 6.42

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

Share on Social Networks: